Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2024-2030
The Clinical Trial Supply & Logistics Market size was estimated at USD 24.33 billion in 2023 and expected to reach USD 26.20 billion in 2024, at a CAGR 7.75% to reach USD 41.04 billion by 2030.
Clinical trial supply & logistics encompasses the planning, management, storage, and distribution of clinical trial materials (CTMs) needed to conduct clinical studies. These materials include investigational medicinal products (IMPs), placebos, patient kits, ancillary supplies, and labeling services. The main objective of CTSL is to ensure that clinical trials are conducted efficiently and in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines while maintaining product quality and integrity. The prevalence of chronic disorders and increasing government investments in pharmaceutical research & development process drives the use of clinical trial supply & logistics. On the contrary, the cost-intensive nature of clinical trials and the limited availability of trained professionals hinders market growth. However, growing interest in drug development projects coupled with outsourcing clinical trials is expected to increase its usage in the coming years.
Regional Insights
In the Americas region, North America has considerable utilization of clinical trial supply & logistics, with the United States leading the growth with its robust pharmaceutical industry and extensive investment in research and development (R&D). Furthermore, numerous leading pharmaceutical companies conducting clinical trials and strong government support for R&D activities drive market expansion. South America also contributes to increasing clinical trial supply & logistics usage due to its developing healthcare infrastructure and growing focus on clinical research. The Asia-Pacific region’s clinical trial supply & logistics market is growing rapidly due to its rapidly evolving pharmaceutical industry in China, India, South Korea, Taiwan, Indonesia, and Vietnam, among others. Moreover, many multinational pharmaceutical companies have established their R&D centers or collaborations with local partners in this region due to resource availability at competitive prices. Within the EMEA region, Europe has been traditionally considered a stronghold for the global clinical trial supply & logistics market due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products (IMPs). In addition, Middle East & Africa are emerging markets within the EMEA region due to increasing healthcare expenditure by governments, expansion of multinational pharmaceutical companies into these markets to tap a larger patient pool for testing their investigational drugs/devices, continuous development of healthcare infrastructure and availability of skilled workforce due to their investments in education.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Clinical Trial Supply & Logistics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
- Globalization of clinical trials and harmonization of regulations
- Market Restraints
- Problems associated with technology integration and data management
- Market Opportunities
- Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
- Increasing partnership activities between pharmaceutical manufacturers and CDMOs
- Market Challenges
- Concerns associated with the operations within clinical trial supply and logistics
- Market Segmentation Analysis
- Services: Continuous advancements in cold chain distribution services with growing demand
- Type: Surging utilization of small molecules in the pharmaceutical sector
- Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
- Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
- End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Supply & Logistics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Supply & Logistics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- PCM Trials acquires Netherlands-based Clinical Trial Service
PCM Trials, a decentralized clinical trial solutions provider through its mobile research nurses, announced the acquisition of Clinical Trial Service (CTS), a clinical research organization based in Losser, Netherlands. This strategic acquisition substantially enlarges PCM Trials' global operations, reinforcing its commitment to delivering exceptional decentralized clinical trial services worldwide.
Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
Piramal Pharma Solutions (PPS), a Contract Development and Manufacturing Organization (CDMO) integral to Piramal Pharma Ltd. (PPL), marked the inauguration of its enhanced antibody-drug conjugate (ADC) production site situated in Grangemouth, Scotland. This expansion underscores PPS's commitment to advancing its capabilities in the ADC manufacturing sphere, thereby reinforcing its position as a pivotal player in the pharmaceutical and biotechnological industry's supply chain.
Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
Biocair, a life science logistics firm, significantly upgraded and relocated its Chicago operations. Emphasizing its commitment to growth and enhancing service delivery, the company has transitioned from a facility spanning 2,904 square feet to a new, larger space of 7,213 square feet. This expansion, located three miles from the vital cargo hub at O'Hare International Airport, more than doubles Biocair's operational capacity, underscoring its strategy to scale operations and improve logistics solutions across its global network.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Supply & Logistics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.
Market Segmentation & Coverage
This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:- Services
- Comparator Sourcing
- Logistics & Distribution
- Cold Chain Distribution
- Non-Cold Chain Distribution
- Manufacturing
- Packaging, Labeling, & Blinding
- Storage & Retention
- Type
- Biologic Drugs
- Medical Devices
- Small Molecules
- Phase
- BA/ BE studies
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Therapeutic Area
- Blood Disorders
- Cardiovascular Diseases
- CNS & Mental Disorders
- Dermatological Disorders
- Digestive Disorders
- ENT Diseases
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Nephrology
- Oncology
- Rare Diseases
- Respiratory Disorders
- End User
- Contract Research Organisations
- Medical Devices Companies
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- Massachusetts
- Minnesota
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
- 5.1.1.2. Globalization of clinical trials and harmonization of regulations
- 5.1.2. Restraints
- 5.1.2.1. Problems associated with technology integration and data management
- 5.1.3. Opportunities
- 5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
- 5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
- 5.1.4. Challenges
- 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
- 5.2. Market Segmentation Analysis
- 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
- 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
- 5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
- 5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
- 5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
- 5.3. Market Trend Analysis
- 5.3.1. Strong pharmaceutical production capability and integration of advanced technologies in the supply chain across the Americas
- 5.3.2. Expanding healthcare sectors coupled with supportive government initiatives augmenting clinical trial logistics across APAC region
- 5.3.3. Robust presence of market players and continuous focus on advancing pharmaceutical supply chain across EMEA region
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 5.8. Client Customization
- 5.8.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
- 5.8.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
- 5.8.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
- 5.8.4. Eurofins Scientific Group: Eurofins Scientific Group’s focus on conferences and fairs for effective product marketing
- 5.8.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
- 5.8.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
- 5.8.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
- 5.8.8. Small Molecules: Need to address intense competition and regulatory complexities
- 5.8.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services
- 6. Clinical Trial Supply & Logistics Market, by Services
- 6.1. Introduction
- 6.2. Comparator Sourcing
- 6.3. Logistics & Distribution
- 6.4. Manufacturing
- 6.5. Packaging, Labeling, & Blinding
- 6.6. Storage & Retention
- 7. Clinical Trial Supply & Logistics Market, by Type
- 7.1. Introduction
- 7.2. Biologic Drugs
- 7.3. Medical Devices
- 7.4. Small Molecules
- 8. Clinical Trial Supply & Logistics Market, by Phase
- 8.1. Introduction
- 8.2. BA/ BE studies
- 8.3. Phase 1
- 8.4. Phase 2
- 8.5. Phase 3
- 8.6. Phase 4
- 9. Clinical Trial Supply & Logistics Market, by Therapeutic Area
- 9.1. Introduction
- 9.2. Blood Disorders
- 9.3. Cardiovascular Diseases
- 9.4. CNS & Mental Disorders
- 9.5. Dermatological Disorders
- 9.6. Digestive Disorders
- 9.7. ENT Diseases
- 9.8. Immunology
- 9.9. Infectious Diseases
- 9.10. Metabolic Disorders
- 9.11. Nephrology
- 9.12. Oncology
- 9.13. Rare Diseases
- 9.14. Respiratory Disorders
- 10. Clinical Trial Supply & Logistics Market, by End User
- 10.1. Introduction
- 10.2. Contract Research Organisations
- 10.3. Medical Devices Companies
- 10.4. Pharmaceutical & Biotechnology Companies
- 11. Americas Clinical Trial Supply & Logistics Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Clinical Trial Supply & Logistics Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2023
- 14.2. FPNV Positioning Matrix, 2023
- 14.3. Competitive Scenario Analysis
- 14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
- 14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
- 14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
- 14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
- 14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
- 14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
- 14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
- 14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
- 14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
- 14.3.10. Vial Announces Strategic Partnership with Royale International Group
- 14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
- 14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
- 14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
- 14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
- 14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
- 14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
- 14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook